Cardiology in Fetus of Diabetic Mother Clinical Trial
Official title:
Cardiac Septal Hypertrophy in the Fetus of Diabetic Mother and Its Effect on Postnatal Cardiac Function
Verified date | May 2012 |
Source | Ain Shams Maternity Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | Egypt:AinShamsMH |
Study type | Observational |
Good glycemic control is superior to poor glycemic control in reducing risk of interventricular septum thickness among fetuses of diabetic mothers
Status | Enrolling by invitation |
Enrollment | 120 |
Est. completion date | March 2013 |
Est. primary completion date | February 2013 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 45 Years |
Eligibility |
Inclusion Criteria: - singleton pregnancy - gestational age 36 weeks Exclusion Criteria: - congenital anomalies - obstetric complications - medical disorders other than diabetes |
Time Perspective: Cross-Sectional
Country | Name | City | State |
---|---|---|---|
Egypt | AinShamsMH | Cairo |
Lead Sponsor | Collaborator |
---|---|
Ain Shams Maternity Hospital |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control. | To study interventricular septum thickness in fetus of diabetic mother and correlate it with good glycemic control during third trimester of pregnancy. | one year | No |
Secondary | cardiac function in infant of diabetic mother | To correlate postnatal cardiac function to interventricular septum thickness to reach cut of value of septum thickness for prenatal prediction of symptomatic cardiomyopathy in infant of diabetic mother. | one year | No |